Eagle Pharmaceuticals, Inc. to Present at 43rd Annual Deutsche Bank Health Care Conference

The presentation will be webcast live at the aforementioned time, and archived for 90 days thereafter, via the company’s website at www.eagleus.com, under the Investors Section and is also available at https://edge.media-server.com/m6/p/m6gfqywb.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the Company’s website at www.eagleus.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180430006397/en/